Skip to main content
NCBI home page
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2011 Jun 30;67(Pt 7):762–767. doi: 10.1107/S1744309111016770

Expression, purification, crystallization and preliminary crystallographic analysis of a putative Clostridium difficile surface protein Cwp19

Jonathan M Kirby a,b, Nethaji Thiyagarajan a, April K Roberts b, Clifford C Shone b, K Ravi Acharya a,*
PMCID: PMC3144791  PMID: 21795789

Cwp19 is a putatively surface-located protein from Clostridium difficile. A recombinant N-terminal protein (residues 27–401) lacking the signal peptide and the C-terminal cell-wall-binding repeats (PFam04122) was crystallized using the sitting-drop vapour-diffusion method and diffracted to 2 Å resolution.

Keywords: Cwp19, Clostridium difficile, surface proteins

Abstract

Cwp19 is a putatively surface-located protein from Clostridium difficile. A recombinant N-terminal protein (residues 27–401) lacking the signal peptide and the C-terminal cell-wall-binding repeats (PFam04122) was crystallized using the sitting-drop vapour-diffusion method and diffracted to 2 Å resolution. The crystal appeared to belong to the primitive monoclinic space group P21, with unit-cell parameters a = 109.1, b = 61.2, c = 109.2 Å, β = 111.85°, and is estimated to contain two molecules of Cwp19 per asymmetric unit.

1. Introduction

Clostridium difficile is a Gram-positive spore-forming primarily nosocomial pathogen that is the aetiological agent in antibiotic-associated diarrhoea and pseudomembranous colitis (Bartlett, 2010 ▶). Changes in epidemiology and disease severity, particularly in strains that have emerged over the last ten years, e.g. the 027 ribotype, highlight the need to understand more about this worldwide pathogen (Freeman et al., 2010 ▶).

The elucidation of structural information for C. difficile proteins has understandably been directed towards the main virulence factors, the toxins (Albesa-Jové et al., 2010 ▶; Ho et al., 2005 ▶; Pruitt et al., 2009 ▶, 2010 ▶; Sundriyal et al., 2009 ▶). Despite adherence and subsequent colonization by C. difficile representing key milestones in infection, there are considerable gaps in the understanding of how the surface proteins of C. difficile interact with both themselves and the environment to mediate these key steps. To date, there is only one report of high-resolution structural information for a C. difficile surface protein: the low-molecular-weight subunit of the S-layer (PDB entry 3cvz; Fagan et al., 2009 ▶).

The C. difficile S-layer is derived from post-translational cleavage of SlpA into low-molecular-weight and high-molecular-weight sub­units (LMW SLP and HMW SLP, respectively). HMW SLP contains three PFam04122 repeats which putatively mediate attachment to the bacterial cell surface (cell-wall-binding domains; CWBDs). A total of 28 other proteins in the C. difficile 630 genome have been found to contain these CWBDs at the N-terminus or the C-terminus, with a ‘functional domain’ at the other terminus (Sebaihia et al., 2006 ▶). Recently, Dang et al. (2010 ▶) identified one such CWBD-containing protein, Cwp19 (CD2767; C. difficile 630 genome numbering; Fagan et al., 2011 ▶; Sebaihia et al., 2006 ▶), during a pull-down assay of ABP-labelled Cwp84. Cwp19 has an N-terminal DUF187 domain (together with three C-­terminal CWBDs) which belongs to a glycosyl hydrolase clan of enzymes that possess a TIM barrel (a conserved protein fold consisting of eight α-helices and eight parallel β-strands that alternate along the peptide backbone, as originally identified in the conserved glycolytic enzyme triosephosphate isomerase). Other members include α-amylases and cellulases.

To understand the molecular structure of this protein, the N-­terminal domain of Cwp19, lacking the CWBDs, has been expressed, purified and crystallized for structural studies.

2. Materials and methods

2.1. Cloning

A synthesized gene (GENEART, Germany) corresponding to the N-terminus lacking the predicted signal peptide and CWBDs (residues 27–401) of cwp19 from C. difficile QCD32g-58 was cloned into pET28a using NdeI and EcoRI. The resulting rCwp1927–401 protein had a 21-amino-acid leader sequence including a His6 tag (MGSS­HHHHHHSSGLVPRGSHM).

2.2. Expression and purification

The cwp19 construct was transformed into Escherichia coli BL21 (DE3) Star (Invitrogen). A single colony was used to inoculate 50 ml Terrific Broth (TB) medium (Sigma) with 50 µg ml−1 kanamycin supplemented with 0.5% glucose and grown overnight at 303 K. The starter culture was then inoculated into 950 ml of the aforementioned supplemented TB medium and grown until the OD reached ∼0.6. Cultures were then cooled to 289 K, induced with 1 mM IPTG and grown for a further 16 h before harvesting by centrifugation. Cell pellets were either used directly or frozen at 253 K.

The cell pellet was thawed on ice, resuspended in immobilized metal-affinity chromatography (IMAC) binding/wash buffer (50 mM Tris, 0.5 M NaCl, 20 mM imidazole pH 8.0), sonicated and centrifuged to remove cell debris. IMAC was performed on an ÄKTA design FPLC (GE Healthcare) using a HisTrap HP (GE Healthcare) column equilibrated with binding/wash buffer. Elution was performed using an imidazole gradient (elution buffer: 50 mM Tris, 0.5 M NaCl, 0.5 M imidazole pH 8.0). Early elution peak fractions were dialysed into 50 mM Tris, 150 mM NaCl pH 8.0, 0.2 µm filtered and then concentrated in a Vivaspin-20 10k MWCO spin concentrator to approximately 167 mg ml−1 (as measured by the Bradford assay using 1 mg ml−1 BSA as the standard). Purity was assessed by SDS–PAGE and anti-His6 Western blot.

2.3. Crystallization

Using a nanodispensing robot (Art Robbins Instruments), sitting-drop vapour-diffusion crystallization trials were set up in 96-well Intelli-Plates (Art Robbins Instruments) and incubated at 289 K. Appropriate amounts of protein solution and reservoir solution were dispensed to give 2:1, 1:1 and 1:2 ratios (using 150 or 300 nl volumes). The following screens were assessed: PACT premier, JCSG-plus, Structure Screen 1 and 2 HT-96, MemGold and Morpheus (Molecular Dimensions). A large crystal appeared after ∼4 months in well D10 of Structure Screen 1 and 2 HT-96 [0.05 M potassium dihydrogen phosphate, 20%(w/v) PEG 8000] using a 1:1 protein:reservoir ratio.

2.4. X-ray data collection and processing

A total of 250 images were recorded from a single crystal of rCwp1927–401 using a Quantum-4 CCD detector (ADSC Systems, California, USA) with an oscillation angle of 1.0° per image, a crystal-to-detector distance of 300 mm and an exposure time of 3 s per image at 100 K (no cryoprotectant was used) on the PX beamline I04 at the Diamond Light Source (Didcot, Oxon, England). The diffraction data were processed using the iMOSFLM X-ray data-processing package (Battye et al., 2011 ▶) and were scaled using SCALA (part of the CCP4 program suite; Winn et al., 2011 ▶). Data-collection and processing statistics are listed in Table 1 ▶. Molecular-replacement trials were attempted using the PHENIX suite of crystallography programs (Adams et al., 2010 ▶).

Table 1. Statistics for the processing of X-ray data from the rCwp1927–401 crystal in various possible space groups using iMOSFLM .

Values in parentheses are for the highest resolution shell

Space group C222/C2221 C2 P2/P21 P1
Unit-cell parameters (Å, °) a = 122.4, b = 181.18, c = 61.3, α = β = γ = 90.0 a = 122.3, b = 180.8, c = 61.2, α = γ = 90.0, β = 89.98 a = 109.1, b = 61.2, c = 109.2, α = γ = 90.0, β = 111.9 a = 61.23, b = 109.2, c = 109.3, α = 111.8, β = 90.1, γ = 89.9
Resolution range (Å) 50–2.00 (2.11–2.00) 50–2.00 (2.11–2.00) 50–2.00 (2.11–2.00) 50–2.00 (2.11–2.00)
Rmerge 0.502 (0.656) 0.489 (0.666) 0.135 (0.538) 0.100 (0.439)
Rp.i.m. 0.173 (0.258) 0.234 (0.354) 0.074 (0.306) 0.082 (0.351)
〈I/σ(I)〉 3.6 (2.2) 2.8 (1.3) 6.3 (2.6) 5.4 (2.0)
Completeness (%) 98.3 (97.8) 97.9 (95.9) 91.4 (82.9) 84.3 (75.6)
Total No. of reflections 348929 (43885) 372261 (47129) 363675 (45705) 371347 (46962)
No. of unique reflections 45719 (6575) 87734 (12542) 83202 (10948) 150187 (19737)
Multiplicity 7.6 (6.7) 4.2 (3.8) 4.4 (4.2) 2.5 (2.4)
Wilson B factor (Å2) 23.1 22.1 21.0 21.2
Average mosaicity (°) 1.2 1.1 1.1 1.1
Open in a new tab

3. Results and discussion

3.1. Protein expression and crystallization

Despite the identification of 28 SlpA paralogues containing a Pfam 04122 (cell-wall-binding domain, CWBD), only 11 have been either identified on the cell surface or have had their transcription demonstrated (Calabi et al., 2001 ▶; Karjalainen et al., 2001 ▶; Wright et al., 2005 ▶). The role of CWBD-containing surface proteins in the physiology and pathogenesis of C. difficile has therefore only started to be understood and requires further work.

To obtain pure rCwp19 it was necessary to express only the N-­terminal functional domain, residues 27–401 (minus the predicted signal peptide, residues 1–26), containing the predicted glycosidase catalytic core. The full-length protein (including the CWBDs but also lacking the signal peptide) exhibited extensive truncation/degradation and purification issues. IMAC purification yielded a pure (>90%) 47 kDa species in one step, particularly early in the elution peak (Fig. 1 ▶). rCwp1927–401 had a tendency to dimerize when purified or dialysed in phosphate buffers. However, we could concentrate the protein to a final concentration of 167 mg ml−1.

Figure 1.

Figure 1

Open in a new tab

Purification of rCwp1927–401. The first seven lanes contain material obtained using Tris-based IMAC buffers. Lane L, E. coli lysate. Lane FT, unbound material. Lanes E1–5, eluted fractions from early (E1) and late (E5) in the eluted peak. Lane E1 (PO4), early-eluted fraction from sodium phosphate (monobasic) based IMAC buffers.

Using an automated high-throughput sitting-drop vapour-diffusion technique, crystals were obtained in condition D10 of Structure Screen 1 and 2 HT-96 [0.05 M potassium dihydrogen phosphate, 20%(w/v) PEG 8000]. The crystal (Fig. 2 ▶) grew after approximately four months and diffracted to 2.0 Å resolution (Fig. 3 ▶).

Figure 2.

Figure 2

Open in a new tab

Crystal of rCwp1927–401.

Figure 3.

Figure 3

Open in a new tab

X-ray diffraction image collected from the crystal of rCwp1927–401 at Diamond Light Source (Oxon, England).

3.2. Space-group ambiguity

The X-ray diffraction data for the crystal of rCwp1927–401 were analyzed by processing the data in all suggested space groups using the iMOSFLM software suite (Battye et al., 2011 ▶). The data were processed in centred orthorhombic, centred and primitive monoclinic and primitive triclinic space groups. The final data-processing statistics for all of these possible space groups are given in Table 1 ▶. POINTLESS (Winn et al., 2011 ▶) suggested the primitive monoclinic system as a possible space group for the rCwp1927–401 crystal; how­ever, we also analysed the data for the presence of pseudotranslational symmetry (Adams et al., 2010 ▶; Winn et al., 2011 ▶; Vagin & Teplyakov, 1997 ▶; Vaguine et al., 1999 ▶) and complete/partial mero­hedral twinning (Padilla & Yeates, 2003 ▶; French & Wilson, 1978 ▶; Adams et al., 2010 ▶; Winn et al., 2011 ▶). These analyses were performed for data processed in centred orthorhombic, primitive monoclinic and primitive triclinic space groups using TRUNCATE (Winn et al., 2011 ▶; French & Wilson, 1978 ▶), phenix.xtriage (Adams et al., 2010 ▶), the L-­test (Adams et al., 2010 ▶; Padilla & Yeates, 2003 ▶) and the H-test (Lebedev et al., 2006 ▶). Patterson maps were calculated using MOLREP (Vagin & Teplyakov, 2010 ▶) and POLARRFN from the CCP4 package (Winn et al., 2011 ▶).

3.2.1. Twinning analysis

TRUNCATE analysis showed normalized structure amplitudes 〈E〉 of 0.928 and 0.889 for the centred orthorhombic and primitive monoclinic space groups, respectively. The expected value for an untwinned data set is 0.886 and that for a perfectly twinned data set is 0.94. Thus, TRUNCATE indicated the presence of partial twinning in the centred orthorhombic space group with a twin fraction of 0.218. Twinning was not detected by TRUNCATE in the primitive monoclinic space group.

The L-test analysis (Adams et al., 2010 ▶; Padilla & Yeates, 2003 ▶) gave multivariate Z scores of 20.34 and 4.59 for the centred ortho­rhombic and primitive monoclinic space groups, respectively (Figs. 4 ▶ a and 4 ▶ b), indicating the presence of perfect twinning in the centred ortho­rhombic system. For untwinned data and where pseudosymmetry may be absent, the Z score is expected to be <3.5; this is not the case for the primitive monoclinic space group. The mean |L| values were 0.334 and 0.432 for the centred orthorhombic and primitive monoclinic systems, respectively. For a perfectly twinned case this value should be 0.375 and for an untwinned data set the value should be 0.500. In the present case, the value for the primitive monoclinic space group is closer to that for untwinned data. A similar L-test analysis for the primitive triclinic system resulted in a mean |L| value of 0.442 and a multivariate Z score of 3.593.

Figure 4.

Figure 4

Open in a new tab

L-test analysis for space groups C222/C2221 (a) and P2/P21 (b). Curved line, perfect twin; straight line, untwinned; blue line with marks, observed data.

The H-test (Lebedev et al., 2006 ▶) analysis gave a twin fraction of 0.022 for both the primitive monoclinic and primitive triclinic space groups. In the case of untwinned data the expected mean |H| value should be 0.50; values of 0.482 and 0.499 were found for the primitive monoclinic and primitive triclinic space groups, respectively. The H-­test was not performed for the centred orthorhombic system as there are no twin laws available for this space group.

The various twinning tests may appear to have erratic or high twin-fraction results because the data do not scale well in centred space groups (C2 or C222; Table 1 ▶). However, twinning may be absent in the primitive monoclinic space group.

3.2.2. Pseudotranslational symmetry analysis

The presence of noncrystallographic symmetry (NCS) was tested for using MOLREP (Vagin & Teplyakov, 2010 ▶) and phenix.xtriage (Adams et al., 2010 ▶). Both indicated the presence of pseudotranslational NCS in the centred orthorhombic and primitive monoclinic space groups. A strong off-origin peak was found in all these space groups. In the primitive monoclinic and primitive triclinic systems the strength of the off-origin peak was 50% of the origin peak, whereas in the centred orthorhombic space group it was only 23%. The corresponding p-values (calculated using phenix.xtriage) are 0.00520, 6.8 × 10−5 and 7.2 × 10−5 for the centred orthorhombic, primitive monoclinic and primitive triclinic systems, respectively (a p-value of <0.05 indicates the presence of pseudotranslational NCS). A self-rotation function was also calculated in the centred orthorhombic (Figs. 5 ▶ a and 5 ▶ b), primitive monoclinic (Figs. 6 ▶ a and 6 ▶ b) and primitive triclinic (Fig. 7 ▶) space groups using MOLREP and POLARRFN (Winn et al., 2011 ▶).

Figure 5.

Figure 5

Open in a new tab

Self-rotation Patterson maps for space group C222 as calculated by (a) MOLREP and (b) POLARRFN (κ = 90°).

Figure 6.

Figure 6

Open in a new tab

Self-rotation Patterson maps for space group P2 as calculated by (a) MOLREP and (b) POLARRFN (κ = 180°).

Figure 7.

Figure 7

Open in a new tab

Self-rotation Patterson maps for space group P1 as calculated by MOLREP.

3.2.3. Data-processing statistics and point-group analysis

The X-­ray data-processing statistics indicated that the centred ortho­rhombic space group had an overall 〈I/σ(I)〉 of 3.6 and an overall merging R of 0.50, compared with the primitive monoclinic space group which had an overall 〈I/σ(I)〉 of 6.3 and an overall merging R of 0.135. The corresponding values for the centred monoclinic space group were 2.8 and 0.489 for the overall 〈I/σ(I)〉 and overall merging R, respectively. For the primitive triclinic system these values were 5.4 and 0.100 for the overall 〈I/σ(I)〉 and overall merging R, respectively. Similarly, the overall R p.i.m. (Evans, 2006 ▶; Leslie, 1992 ▶) values were also high for the centred orthorhombic and centred monoclinic space groups compared with the primitive monoclinic and primitive triclinic systems (Table 1 ▶).

Analysis of systematic absences (Adams et al., 2010 ▶) confirmed the presence of a twofold 21 screw axis in both the centred orthorhombic and primitive monoclinic space groups. There were three and two violations with 〈I/σ(I)〉 > 3.0 for the centred orthorhombic space groups C222 and C2221, respectively, whereas for the primitive monoclinic space groups P2 and P21 there were zero and four violations with 〈I/σ(I)〉 > 3.0, respectively. However, the likelihoods for the centred orthorhombic and primitive monoclinic space groups are 7 and 1.7, respectively (as calculated using phenix.xtriage; Adams et al., 2010 ▶).

A point-group test performed by phenix.xtriage (Adams et al., 2010 ▶) suggested the reprocessing of data that were processed previously in the centred orthorhombic space group, which could have resulted as a consequence of over-merging of pseudo-symmetry and/or twinned data, i.e. this is possibly not the correct space group. A similar point-group test was carried out for data processed in the primitive monoclinic space group, which suggested this could be the correct space group, with unit-cell parameters a = 109.1, b = 61.2, c = 109.2 Å, β = 111.9°. A point-group test in the primitive triclinic system also suggested a primitive monoclinic space group with identical unit-cell parameters and a likelihood score of 3.0.

Based on the various analyses performed, the data-processing statistics and suggestions from POINTLESS (Winn et al., 2011 ▶) and phenix.xtriage (Adams et al., 2010 ▶), we conclude that the crystal of rCwp1927–401 could belong to a primitive monoclinic space group. In addition, phenix.xtriage analysis of data processed in the primitive monoclinic space group detected the presence of pseudo-translational noncrystallographic symmetry (which could be the reason for the elevated intensity ratios observed) and twinning could be present. Hence, twin laws are applicable to this crystal symmetry and this could be the reason for the departure of the intensity statistics from normality.

3.3. Low sequence homology

BLASTP (http://blast.ncbi.nlm.nih.gov) analysis revealed that Cwp1927–401 has low sequence homology to known protein structures in the PDB; the closest available structure (PDB entries 1eh9 and 1eha; Feese et al., 2000 ▶) shares 24% identity (44% similarity) but only over 35% of Cwp1927–401. Given the proposed space group, molecular-replacement trials were attempted in space group P21 using homology models generated by SWISS-MODEL (Arnold et al., 2006 ▶) [based on PDB entries 2gsj (Cavada et al., 2006 ▶) and 3bxw (Meng et al., 2010 ▶)] or Phyre (Kelley & Sternberg, 2009 ▶) [based on PDB entry 1m7x (Abad et al., 2002 ▶)], but were unsuccessful presumably owing to low sequence identity (12.7% for 2gsj, 7.8% for 3bxw and 17% for 1m7x). Molecular modelling using the aforementioned servers together with HHPred (Söding et al., 2005 ▶) and I-TASSER (Roy et al., 2010 ▶) suggests that Cwp1927–401 has homology to proteins with a TIM-barrel structure. We are currently attempting to solve the structure of rCwp1927–401 using experimental phasing methods.

Acknowledgments

This work was funded by the National Institute for Health Research Centre for Health Protection Research at the Health Protection Agency (a postgraduate studentship to JMK). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. We would also like to thank the Wellcome Trust (UK) for the equipment grant (No. 088464), the Royal Society for an Industry Fellowship to KRA and the scientists on PX beamline I04 at the Diamond Light Source (Oxon, England).

References

  1. Abad, M. C., Binderup, K., Rios-Steiner, J., Arni, R. K., Preiss, J. & Geiger, J. H. (2002). J. Biol. Chem. 277, 42164–42170. [DOI] [PubMed]
  2. Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.
  3. Albesa-Jové, D., Bertrand, T., Carpenter, E. P., Swain, G. V., Lim, J., Zhang, J., Haire, L. F., Vasisht, N., Braun, V., Lange, A., von Eichel-Streiber, C., Svergun, D. I., Fairweather, N. F. & Brown, K. A. (2010). J. Mol. Biol. 396, 1260–1270. [DOI] [PubMed]
  4. Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. (2006). Bioinformatics, 22, 195–201. [DOI] [PubMed]
  5. Bartlett, J. G. (2010). Ann. N. Y. Acad. Sci. 1213, 62–69. [DOI] [PubMed]
  6. Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. (2011). Acta Cryst. D67, 271–281. [DOI] [PMC free article] [PubMed]
  7. Calabi, E., Ward, S., Wren, B., Paxton, T., Panico, M., Morris, H., Dell, A., Dougan, G. & Fairweather, N. (2001). Mol. Microbiol. 40, 1187–1199. [DOI] [PubMed]
  8. Cavada, B. S. et al. (2006). FEBS J, 273, 3962–3974. [DOI] [PubMed]
  9. Dang, T. H., de la Riva, L., Fagan, R. P., Storck, E. M., Heal, W. P., Janoir, C., Fairweather, N. F. & Tate, E. W. (2010). ACS Chem. Biol. 5, 279–285. [DOI] [PubMed]
  10. Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
  11. Fagan, R. P., Albesa-Jové, D., Qazi, O., Svergun, D. I., Brown, K. A. & Fairweather, N. F. (2009). Mol. Microbiol. 71, 1308–1322. [DOI] [PubMed]
  12. Fagan, R. P., Janoir, C., Collignon, A., Mastrantonio, P., Poxton, I. R. & Fairweather, N. F. (2011). J. Med. Microbiol., doi:10.1099/jmm.0.028472-0. [DOI] [PubMed]
  13. Feese, M. D., Kato, Y., Tamada, T., Kato, M., Komeda, T., Miura, Y., Hirose, M., Hondo, K., Kobayashi, K. & Kuroki, R. (2000). J. Mol. Biol. 301, 451–464. [DOI] [PubMed]
  14. Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J. & Wilcox, M. H. (2010). Clin. Microbiol. Rev. 23, 529–549. [DOI] [PMC free article] [PubMed]
  15. French, S. & Wilson, K. (1978). Acta Cryst. A34, 517–525.
  16. Ho, J. G., Greco, A., Rupnik, M. & Ng, K. K.-S. (2005). Proc. Natl Acad. Sci. USA, 102, 18373–18378. [DOI] [PMC free article] [PubMed]
  17. Karjalainen, T., Waligora-Dupriet, A. J., Cerquetti, M., Spigaglia, P., Maggioni, A., Mauri, P. & Mastrantonio, P. (2001). Infect. Immun. 69, 3442–3446. [DOI] [PMC free article] [PubMed]
  18. Kelley, L. A. & Sternberg, M. J. (2009). Nature Protoc. 4, 363–371. [DOI] [PubMed]
  19. Lebedev, A. A., Vagin, A. A. & Murshudov, G. N. (2006). Acta Cryst. D62, 83–95. [DOI] [PubMed]
  20. Leslie, A. G. W. (1992). Jnt CCP4/ESF–EACBM Newsl. Protein Crystallogr. 26
  21. Meng, G., Zhao, Y., Bai, X., Liu, Y., Green, T. J., Luo, M. & Zheng, X. (2010). J. Biol. Chem. 285, 39898–39904. [DOI] [PMC free article] [PubMed]
  22. Padilla, J. E. & Yeates, T. O. (2003). Acta Cryst. D59, 1124–1130. [DOI] [PubMed]
  23. Pruitt, R. N., Chagot, B., Cover, M., Chazin, W. J., Spiller, B. & Lacy, D. B. (2009). J. Biol. Chem. 284, 21934–21940. [DOI] [PMC free article] [PubMed]
  24. Pruitt, R. N., Chambers, M. G., Ng, K. K.-S., Ohi, M. D. & Lacy, D. B. (2010). Proc. Natl Acad. Sci. USA, 107, 13467–13472. [DOI] [PMC free article] [PubMed]
  25. Roy, A., Kucukural, A. & Zhang, Y. (2010). Nature Protoc. 5, 725–738. [DOI] [PMC free article] [PubMed]
  26. Sebaihia, M. et al. (2006). Nature Genet. 38, 779–786. [DOI] [PubMed]
  27. Söding, J., Biegert, A. & Lupas, A. N. (2005). Nucleic Acids Res. 33, W244–W248. [DOI] [PMC free article] [PubMed]
  28. Sundriyal, A., Roberts, A. K., Shone, C. C. & Acharya, K. R. (2009). J. Biol. Chem. 284, 28713–28719. [DOI] [PMC free article] [PubMed]
  29. Vagin, A. & Teplyakov, A. (1997). J. Appl. Cryst. 30, 1022–1025.
  30. Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
  31. Vaguine, A. A., Richelle, J. & Wodak, S. J. (1999). Acta Cryst. D55, 191–205. [DOI] [PubMed]
  32. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
  33. Wright, A., Wait, R., Begum, S., Crossett, B., Nagy, J., Brown, K. & Fairweather, N. (2005). Proteomics, 5, 2443–2452. [DOI] [PubMed]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES